Long‐Term Effects of Sglt2 Deletion on Bone and Mineral Metabolism in Mice
ABSTRACT Sodium‐glucose cotransporter 2 (SGLT2) inhibitors improve kidney and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM). However, bone fragility has emerged as a side effect in some but not in all human studies. Because use of SGLT2 inhibitors in humans affects mineral...
| 發表在: | JBMR Plus |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Oxford University Press
2021-08-01
|
| 主題: | |
| 在線閱讀: | https://doi.org/10.1002/jbm4.10526 |